Swartz MA - Search Results

1

Targeted antibody and cytokine cancer immunotherapies through collagen affinity.

Ishihara J, Ishihara A, Sasaki K, Lee SS, Williford JM, Yasui M, Abe H, Potin L, Hosseinchi P, Fukunaga K, Raczy MM, Gray LT, Mansurov A, Katsumata K, Fukayama M, Kron SJ, Swartz MA, Hubbell JA. Ishihara J, et al. Among authors: swartz ma. Sci Transl Med. 2019 Apr 10;11(487):eaau3259. doi: 10.1126/scitranslmed.aau3259. Sci Transl Med. 2019. PMID: 30971453 Free PMC article.

2

In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

Reddy ST, Rehor A, Schmoekel HG, Hubbell JA, Swartz MA. Reddy ST, et al. Among authors: swartz ma. J Control Release. 2006 May 1;112(1):26-34. doi: 10.1016/j.jconrel.2006.01.006. Epub 2006 Mar 10. J Control Release. 2006. PMID: 16529839

3

Targeting dendritic cells with biomaterials: developing the next generation of vaccines.

Reddy ST, Swartz MA, Hubbell JA. Reddy ST, et al. Among authors: swartz ma. Trends Immunol. 2006 Dec;27(12):573-9. doi: 10.1016/j.it.2006.10.005. Epub 2006 Oct 16. Trends Immunol. 2006. PMID: 17049307 Review.

4

Exploiting lymphatic transport and complement activation in nanoparticle vaccines.

Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O'Neil CP, Lee LK, Swartz MA, Hubbell JA. Reddy ST, et al. Among authors: swartz ma. Nat Biotechnol. 2007 Oct;25(10):1159-64. doi: 10.1038/nbt1332. Epub 2007 Sep 16. Nat Biotechnol. 2007. PMID: 17873867

5

Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design.

Swartz MA, Hubbell JA, Reddy ST. Swartz MA, et al. Semin Immunol. 2008 Apr;20(2):147-56. doi: 10.1016/j.smim.2007.11.007. Epub 2008 Jan 16. Semin Immunol. 2008. PMID: 18201895 Free article. Review.

6

Materials engineering for immunomodulation.

Hubbell JA, Thomas SN, Swartz MA. Hubbell JA, et al. Among authors: swartz ma. Nature. 2009 Nov 26;462(7272):449-60. doi: 10.1038/nature08604. Nature. 2009. PMID: 19940915 Review.

7

Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.

Hirosue S, Kourtis IC, van der Vlies AJ, Hubbell JA, Swartz MA. Hirosue S, et al. Among authors: swartz ma. Vaccine. 2010 Nov 23;28(50):7897-906. doi: 10.1016/j.vaccine.2010.09.077. Epub 2010 Oct 8. Vaccine. 2010. PMID: 20934457

8

PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration.

Stano A, van der Vlies AJ, Martino MM, Swartz MA, Hubbell JA, Simeoni E. Stano A, et al. Among authors: swartz ma. Vaccine. 2011 Jan 17;29(4):804-12. doi: 10.1016/j.vaccine.2010.11.010. Epub 2010 Nov 19. Vaccine. 2011. PMID: 21094269

9

Engineering complement activation on polypropylene sulfide vaccine nanoparticles.

Thomas SN, van der Vlies AJ, O'Neil CP, Reddy ST, Yu SS, Giorgio TD, Swartz MA, Hubbell JA. Thomas SN, et al. Among authors: swartz ma. Biomaterials. 2011 Mar;32(8):2194-203. doi: 10.1016/j.biomaterials.2010.11.037. Epub 2010 Dec 22. Biomaterials. 2011. PMID: 21183216

10

Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.

Ballester M, Nembrini C, Dhar N, de Titta A, de Piano C, Pasquier M, Simeoni E, van der Vlies AJ, McKinney JD, Hubbell JA, Swartz MA. Ballester M, et al. Among authors: swartz ma. Vaccine. 2011 Sep 16;29(40):6959-66. doi: 10.1016/j.vaccine.2011.07.039. Epub 2011 Jul 23. Vaccine. 2011. PMID: 21787826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page